Dashboard
Manage Tickers

MRNAModerna, Inc.

Nasdaq modernatx.com


$ 69.67 $ 1.17 (1.72 %)    

Monday, 16-Sep-2024 13:07:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.86 $ -1.20 (-0.25 %)
DIA $ 416.34 $ -0.61 (-0.15 %)
SPY $ 561.51 $ 0.04 (0.01 %)
TLT $ 101.14 $ 0.51 (0.5 %)
GLD $ 238.70 $ 0.10 (0.04 %)
$ 68.28
$ 68.50
$ 69.27 x 100
$ 70.33 x 100
$ 68.04 - $ 70.53
$ 62.55 - $ 170.47
11,969,001
na
26.25B
$ 0.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

desantis-administration-cautions-against-pfizer-moderna-mrna-covid-vaccines-for-vulnerable-individuals-cites-concerns-related-to-rare-heart-conditions
DeSantis Administration Cautions Against P...
09/16/2024 15:18:10

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration...

goldman-sachs-maintains-buy-on-moderna-lowers-price-target-to-139
Goldman Sachs Maintains Buy on Moderna, Lo...
09/16/2024 14:15:49

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $178 to $139.

barclays-maintains-overweight-on-moderna-lowers-price-target-to-125
Barclays Maintains Overweight on Moderna, ...
09/16/2024 13:48:31

Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $155 to $125.

Core News & Articles
US To Stay Committed In Bringing Mpox Outb...
09/16/2024 12:49:38

- Bloomberg

moderna-tyson-foods-and-adobe-are-among-top-10-large-cap-stock-losers-last-week-sep-8-sep-14-are-the-others-in-your-portfolio
Moderna, Tyson Foods And Adobe Are Among T...
09/15/2024 22:44:19

10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your...

moderna-faces-analyst-downgrades-amid-revised-rd-restructured-strategy-and-delayed-profitability-target
Moderna Faces Analyst Downgrades Amid Revi...
09/13/2024 22:34:46

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight ne...

16-analysts-have-this-to-say-about-moderna
16 Analysts Have This To Say About Moderna
09/13/2024 21:00:36

heres-how-much-you-would-have-made-owning-moderna-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
09/13/2024 21:00:18

Core News & Articles
"Florida Discourages Use Of mRNA Covid Vac...
09/13/2024 17:21:41

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

b-of-a-securities-maintains-neutral-on-moderna-lowers-price-target-to-110
B of A Securities Maintains Neutral on Mod...
09/13/2024 16:20:46

B of A Securities analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and lowers the price target from $130...

oracle-to-rally-around-23-here-are-10-top-analyst-forecasts-for-friday
Oracle To Rally Around 23%? Here Are 10 To...
09/13/2024 15:54:34

td-cowen-maintains-hold-on-moderna-lowers-price-target-to-60
TD Cowen Maintains Hold on Moderna, Lowers...
09/13/2024 15:05:43

TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $70 to $60.

rbc-capital-maintains-sector-perform-on-moderna-lowers-price-target-to-75
RBC Capital Maintains Sector Perform on Mo...
09/13/2024 14:12:22

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and lowers the price target from $90 to ...

tradepulse-power-inflow-alert-moderna-inc-rises-89-on-the-trading-day
Tradepulse Power Inflow Alert: Moderna Inc...
09/13/2024 13:42:42

jp-morgan-downgrades-moderna-to-underweight-lowers-price-target-to-70
JP Morgan Downgrades Moderna to Underweigh...
09/13/2024 13:08:12

JP Morgan analyst Jessica Fye downgrades Moderna (NASDAQ:MRNA) from Neutral to Underweight and lowers the price target from ...

jefferies-downgrades-moderna-to-hold-lowers-price-target-to-65
Jefferies Downgrades Moderna to Hold, Lowe...
09/13/2024 13:00:21

Jefferies analyst Michael Yee downgrades Moderna (NASDAQ:MRNA) from Buy to Hold and lowers the price target from $120 to $65.

moderna-shares-are-trading-lower-after-piper-sandler-maintained-an-overweight-rating-on-the-stock-but-lowered-its-price-target-from-157-to-115-also-oppenheimer-downgraded-the-stock-from-outperform-to-perform
Moderna shares are trading lower after Pip...
09/13/2024 11:41:55

oppenheimer-downgrades-moderna-to-perform
Oppenheimer Downgrades Moderna to Perform
09/13/2024 11:23:28

Oppenheimer analyst Hartaj Singh downgrades Moderna (NASDAQ:MRNA) from Outperform to Perform.

piper-sandler-maintains-overweight-on-moderna-lowers-price-target-to-115
Piper Sandler Maintains Overweight on Mode...
09/13/2024 10:59:11

Piper Sandler analyst Edward Tenthoff maintains Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $15...

needham-reiterates-hold-on-moderna
Needham Reiterates Hold on Moderna
09/13/2024 10:45:58

Needham analyst Joseph Stringer reiterates Moderna (NASDAQ:MRNA) with a Hold.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION